The cortico-basal ganglia-thalamocortical loop participates in the regulation of motor movements and goal-directed behaviors [1–4]. Parkinson’s disease (PD), as well as other neurodegenerative disorders that affect motor function, is associated with abnormal neurotransmission along this pathway [5–7]. In this chapter, we will examine how a reduction of dopamine availability in PD produces striatal synaptic plasticity. These striatal adaptations might be sufficient to produce bradykinesia in the dopamine-deficient state and motor dyskinesias following treatment. Although changes occur at several levels of the cortico-basal ganglia-thalamocortical loop, the focus of this chapter is on the corticostriatal synapse.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander, GE, DeLong, MR, Strick, PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9:357–81.
Alexander, GE, Crutcher, MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13(7):266–71.
Albin, RL, Young, AB, Penney, JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12(10):366–75.
Jog, MS, et al. Building neural representations of habits. Science 1999; 286(5445):1745–9.
Haber, SN. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 2003; 26(4): 317–30.
Frankel, M, et al. Obsessions and compulsions in Gilles de la Tourette's syndrome. Neurology 1986; 36(3):378–82.
Mink, JW, Thach WT. Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol 1993; 3(6):950–7.
Wilson, CJ. Corticostriatal neurons of the medial agranular cortex in rats, in Functions of the Cortico-Basal Ganglia Loop, Kimura, M, Graybiel, AM. Editors. 1995, Tokyo: Springer. 50–72.
Kemp, JM, Powell TP. The cortico-striate projection in the monkey. Brain 1970;93(3): 525–46.
Gerfen, CR. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 1984; 311(5985):461–4.
Kita, H, Kitai, ST. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res 1988;447(2):346–52.
Wilson, CJ. Basal Ganglia, in The synaptic organization of the brain, Shepherd, GW. Editor. 1990,Oxford: Oxford University Press,. pp. 279–316.
Pickel, VM, et al. Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum. Brain Res 1981; 225(2): 373–85.
Graybiel, AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990;13(7):244–54.
Bamford, NS, et al., Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron, 2008;58(1):89–103.
Zhang, W, et al. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 2002;22(5):1709–17.
Calabresi, P, et al. Acetylcholine-mediated modulation of striatal function. Trends Neurosci 2000;23(3):120–6.
Hersch, SM, et al. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci 1994;14 (5 Pt 2):3351–63.
Wang, H, Sun, X. Desensitized nicotinic receptors in brain. Brain Res Brain Res Rev 2005;48(3):420–37.
Tepper, J.M., C.J. Wilson, and T. Koos, Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons. Brain Res Rev 2008;58(2):272–81.
Redgrave, P, Prescott, TJ, Gurney, K. Is the short-latency dopamine response too short to signal reward error? Trends Neurosci 1999;22(4):146–51.
Missale, C, et al. Dopamine receptors: from structure to function. Physiol Rev 1998;78(1):189–225.
Levey, AI, et al. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A 1993;90(19):8861–5.
Hersch, SM, et al. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 1995;15 (7 Pt 2):5222–37.
Yung, K.K., et al., Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience, 1995. 65(3): p. 709–30.
Caille, I., B. Dumartin, and B. Bloch, Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res, 1996. 730(1–2): p. 17–31.
Mercuri, N.B., P. Calabresi, and G. Bernardi, Responses of rat substantia nigra compacta neurones tol -DOPA. Br J Pharmacol, 1990. 100(2): p. 257–60.
Wang, H. and V.M. Pickel, Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol, 2002. 442(4): p. 392–404.
Bamford, N.S., et al., Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron, 2004. 42(4): p. 653–63.
Bamford, N.S., et al., Dopamine modulates release from corticostriatal terminals. J Neurosci, 2004. 24(43): p. 9541–52.
Flores-Hernandez, J., E. Galarraga, and J. Bargas, Dopamine selects glutamatergic inputs to neostriatal neurons. Synapse, 1997. 25(2): p. 185–95.
Cepeda, C., N.A. Buchwald, and M.S. Levine, Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci U S A, 1993. 90(20): p. 9576–80.
Cepeda, C., et al., Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol, 2001. 85(2): p. 659–70.
Levine, M.S., et al., Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices. Synapse, 1996. 24(1): p. 65–78.
Kebabian, J.W. and D.B. Calne, Multiple receptors for dopamine. Nature, 1979. 277 (5692): p. 93–6.
Creese, I., Dopamine receptors explained. Trends Neurosci, 1982. 5: p. 40–43.
Gonon, F., Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J Neurosci, 1997. 17(15): p. 5972–8.
Graefe, K.H. and H. Bönish, The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurons, in Handbook of Experimental Pharmacology, U. Trendelenburg and N. Weiner, Editors. 1988, Springer Verlag: Berlin. p. 193–235.
Nirenberg, M.J., et al., The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci, 1996. 16(2): p. 436–47.
Pickel, V.M., M.J. Nirenberg, and T.A. Milner, Ultrastructural view of central catecholaminergic transmission: immunocytochemical localization of synthesizing enzymes, transporters and receptors. J Neurocytol, 1996. 25(12): p. 843–56.
Chergui, K., M.F. Suaud-Chagny, and F. Gonon, Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience, 1994. 62(3): p. 641–5.
Mirenowicz, J. and W. Schultz, Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature, 1996. 379 (6564): p. 449–51.
Bamford, N.S., et al., Dopamine-Deficient Mice Demonstrate Hypersensitive Corticostriatal D2 Receptors. Annals of Neurology, 2004. 56 (Suppl 8): p. S85.
Zhou, Q.Y. and R.D. Palmiter, Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell, 1995. 83(7): p. 1197–209.
Gerfen, C.R. and W.S. Young, 3rd, Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res, 1988. 460(1): p. 161–7.
Gerfen, C.R., et al., D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 1990. 250(4986): p. 1429–32.
DeLong, M.R. and T. Wichmann, Circuits and ircuit disorders of the basal ganglia. Arch Neurol, 2007. 64(1): p. 20–4.
Kawaguchi, Y., C.J. Wilson, and P.C. Emson, Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci, 1990. 10(10): p. 3421–38.
Haber, S.N. and W.J. Nauta, Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry. Neuroscience, 1983. 9(2): p. 245–60.
Vincent, S., et al., Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway. Eur J Pharmacol, 1982. 85(2): p. 251–2.
Steiner, H. and C.R. Gerfen, Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience, 1999. 88(3): p. 795–810.
Grofova, I., Types of striatonigral neurons labeled by retrograde transport of horseradish peroxidase. Appl Neurophysiol, 1979. 42(1–2): p. 25–8.
Cepeda, C., et al., Differential electrophysiological properties of dopamine D1 and D2 receptor-containing medium-sized spiny neurons. Eur J Neurosci, 2008. 27: p. 671–682.
Kreitzer, A.C. and R.C. Malenka, Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature, 2007. 445(7128): p. 643–7.
Day, M., et al., Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci, 2006. 9(2): p. 251–9.
Lei, W., et al., Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J Neurosci, 2004. 24(38): p. 8289–99.
Morishima, M. and Y. Kawaguchi, Recurrent connection patterns of corticostriatal pyramidal cells in frontal cortex. J Neurosci, 2006. 26(16): p. 4394–405.
Berretta, S., H.B. Parthasarathy, and A.M. Graybiel, Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J Neurosci, 1997. 17(12): p. 4752–63.
Smith, Y., et al., The thalamostriatal system: a highly specific network of the basal ganglia circuitry. Trends Neurosci, 2004. 27(9): p. 520–7.
Sidibe, M. and Y. Smith, Differential synaptic innervation of striatofugal neurones projecting to the internal or external segments of the globus pallidus by thalamic afferents in the squirrel monkey. J Comp Neurol, 1996. 365(3): p. 445–65.
Ungerstedt, U., 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol, 1968. 5(1): p. 107–10.
Fischer, E. and B. Heller, Pharmacology of the mechanism of certain effects of reserpine in the rat. Nature, 1967. 216(121): p. 1221–2.
Paladini, C.A., et al., Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism. Proc Natl Acad Sci U S A, 2003. 100(5): p. 2866–71.
Kim, D.S., M.S. Szczypka, and R.D. Palmiter, Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J Neurosci, 2000. 20(12): p. 4405–13.
Chartoff, E.H., et al., Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation. Proc Natl Acad Sci U S A, 2001. 98(18): p. 10451–6.
Levine, M.S., et al., Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect. Trends Neurosci, 2004. 27(11): p. 691–7.
Polymeropoulos, M.H., et al., Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 1997. 276(5321): p. 2045–7.
Spillantini, M.G., et al., Alpha-synuclein in Lewy bodies. Nature, 1997. 388(6645): p. 839–40.
Hashimoto, M., E. Rockenstein, and E. Masliah, Transgenic models of alpha-synuclein pathology: past, present, and future. Ann N Y Acad Sci, 2003. 991: p. 171–88.
Masliah, E., et al., Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science, 2000. 287(5456): p. 1265–9.
Richfield, E.K., et al., Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol, 2002. 175(1): p. 35–48.
Wu, N., et al., Abnormal glutamate and dopamine receptor function in the striatum of α-synuclein-overexpressing mice Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2005. Program No. 85.12.
Shimura, H., et al., Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet, 2000. 25(3): p. 302–5.
Goldberg, M.S., et al., Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem, 2003. 278(44): p. 43628–35.
Itier, J.M., et al., Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet, 2003. 12(18): p. 2277–91.
O'Donnell, P. and A.A. Grace, Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci, 1995. 15(5 Pt 1): p. 3622–39.
Wilson, C.J. and Y. Kawaguchi, The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci, 1996. 16(7): p. 2397–410.
Stern, E.A., A.E. Kincaid, and C.J. Wilson, Spontaneous subthreshold membrane potential fluctuations and action potential variability of rat corticostriatal and striatal neurons in vivo. J Neurophysiol, 1997. 77(4): p. 1697–715.
Wilson, C.J., The generation of natural firing patterns in neostriatal neurons. Prog Brain Res, 1993. 99: p. 277–97.
Cepeda, C., et al., Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. J Neurophysiol, 1998. 79(1): p. 82–94.
Flores-Hernández, J., et al., Multiple pathways are involved in the enhancement of NMDA responses by activation of dopamine D1 receptors in neostriatal neurons. Soc Neurosci Abstr, 1999. 25: p. 1156.
Horvitz, J.C., Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behav Brain Res, 2002. 137(1–2): p. 65–74.
Dani, J.A. and F.M. Zhou, Selective dopamine filter of glutamate striatal afferents. Neuron, 2004. 42(4): p. 522–4.
Calabresi, P., N.B. Mercuri, and G. Bernardi, Synaptic and intrinsic control of membrane excitability of neostriatal neurons. II. An in vitro analysis. J Neurophysiol, 1990. 63(4): p. 663–75.
Kiyatkin, E.A. and G.V. Rebec, Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J Neurophysiol, 1996. 75(1): p. 142–53.
Nicola, S.M., J. Surmeier, and R.C. Malenka, Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci, 2000. 23: p. 185–215.
Cepeda, C. and M.S. Levine, Where do you think you are going? The NMDA-D1 receptor trap. Sci STKE, 2006. 2006(333): p. pe20.
Cepeda, C., et al., Dye-coupling in the neostriatum of the rat: I. Modulation by dopamine-depleting lesions. Synapse, 1989. 4(3): p. 229–37.
Cepeda, C., et al., Intracellular neurophysiological analysis reveals alterations in excitation in striatal neurons in aged rats. Brain Res, 1989. 494(2): p. 215–26.
Hull, C.D., et al., The spontaneous firing pattern of forebrain neurons. I. The effects of dopamine and non-dopamine depleting lesions on caudate unit firing patterns. Brain Res, 1974. 73(2): p. 241–62.
Schultz, W. and U. Ungerstedt, Short-term increase and long-term reversion of striatal cell activity after degeneration of the nigrostriatal dopamine system. Exp Brain Res, 1978. 33(2): p. 159–71.
Calabresi, P., et al., Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain, 1993. 116 (Pt 2): p. 433–52.
Mallet, N., et al., Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. J Neurosci, 2006. 26(14): p. 3875–84.
Florio, T., et al., Influence of prelimbic and sensorimotor cortices on striatal neurons in the rat: electrophysiological evidence for converging inputs and the effects of 6-OHDA-induced degeneration of the substantia nigra. Brain Res, 1993. 619(1–2): p. 180–8.
Tseng, K.Y., et al., Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J Neurosci, 2001. 21(16): p. 6430–9.
Neely, M.D., D.E. Schmidt, and A.Y. Deutch, Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience, 2007. 149(2): p. 457–64.
Schultz, W., Depletion of dopamine in the striatum as an experimental model of Parkinsonism: direct effects and adaptive mechanisms. Prog Neurobiol, 1982. 18(2–3): p. 121–66.
Ito, K., et al., Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem, 1999. 260(1): p. 112–9.
Brotchie, J.M., CB1 cannabinoid receptor signalling in Parkinson's disease. Curr Opin Pharmacol, 2003. 3(1): p. 54–61.
van der Stelt, M. and V. Di Marzo, The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol, 2003. 480(1–3): p. 133–50.
Fernandez-Ruiz, J. and S. Gonzales, Cannabinoid control of motor function at the basal ganglia. Handb Exp Pharmacol, 2005(168): p. 479–507.
Maccarrone, M., et al., Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. J Neurochem, 2003. 85(4): p. 1018–25.
Lastres-Becker, I., et al., Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets. Eur J Neurosci, 2001. 14(11): p. 1827–32.
Fox, S.H., et al., Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Mov Disord, 2002. 17(6): p. 1180–7.
Mackie, K., Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol, 2005(168): p. 299–325.
Glass, M., J.M. Brotchie, and Y.P. Maneuf, Modulation of neurotransmission by cannabinoids in the basal ganglia. Eur J Neurosci, 1997. 9(2): p. 199–203.
Rodriguez, J.J., K. Mackie, and V.M. Pickel, Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J Neurosci, 2001. 21(3): p. 823–33.
Herkenham, M., et al., Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res, 1991. 547(2): p. 267–74.
Ferrer, B., et al., Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci, 2003. 18(6): p. 1607–14.
Giuffrida, A., et al., Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci, 1999. 2(4): p. 358–63.
Beltramo, M., et al., Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J Neurosci, 2000. 20(9): p. 3401–7.
Wilson, R.I. and R.A. Nicoll, Endocannabinoid signaling in the brain. Science, 2002. 296(5568): p. 678–82.
Yin, H.H. and D.M. Lovinger, Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci U S A, 2006. 103(21): p. 8251–6.
Pertwee, R.G. and A.P. Wickens, Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology, 1991. 30(3): p. 237–44.
Maneuf, Y.P., et al., Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. Eur J Pharmacol, 1996. 308(2): p. 161–4.
Di Marzo, V., et al., Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. Faseb J, 2000. 14(10): p. 1432–8.
Silverdale, M.A., et al., Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease. Exp Neurol, 2001. 169(2): p. 400–6.
Brotchie, J., et al., Chemical signalling in the globus pallidus in parkinsonism. Prog Brain Res, 1993. 99: p. 125–39.
DeLong, M.R., Primate models of movement disorders of basal ganglia origin. Trends Neurosci, 1990. 13(7): p. 281–5.
Mitchell, I.J., et al., Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience, 1989. 32(1): p. 213–26.
Barbeau, A., The pathogenesis of Parkinson's disease: a new hypothesis. Can Med Assoc J, 1962. 87: p. 802–7.
Woolf, N.J. and L.L. Butcher, Cholinergic neurons in the caudate-putamen complex proper are intrinsically organized: a combined Evans blue and acetylcholinesterase analysis. Brain Res Bull, 1981. 7(5): p. 487–507.
Aosaki, T., A.M. Graybiel, and M. Kimura, Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. Science, 1994. 265(5170): p. 412–5.
De Vries, G.J., et al., A model system for study of sex chromosome effects on sexually dimorphic neural and behavioral traits. J Neurosci, 2002. 22(20): p. 9005–14.
Wilson, C.J., H.T. Chang, and S.T. Kitai, Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum. J Neurosci, 1990. 10(2): p. 508–19.
Yan, Z., W.J. Song, and J. Surmeier, D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J Neurophysiol, 1997. 77(2): p. 1003–15.
Pisani, A., et al., Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J Neurosci, 2000. 20(7): p. RC69.
DeBoer, P. and E.D. Abercrombie, Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. J Pharmacol Exp Ther, 1996. 277(2): p. 775–83.
Le Moine, C., E. Normand, and B. Bloch, Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci U S A, 1991. 88(10): p. 4205–9.
Bergson, C., et al., Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci, 1995. 15(12): p. 7821–36.
Malenka, R.C. and J.D. Kocsis, Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission studied in vitro. J Neurosci, 1988. 8(10): p. 3750–6.
Wang, Z., et al., Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron, 2006. 50(3): p. 443–52.
Zhang, H. and D. Sulzer, Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci, 2004. 7(6): p. 581–2.
Gomeza, J., et al., Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A, 1999. 96(18): p. 10483–8.
MacKenzie, R.G., M.K. Stachowiak, and M.J. Zigmond, Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine. Eur J Pharmacol, 1989. 168(1): p. 43–52.
DeBoer, P., M.J. Heeringa, and E.D. Abercrombie, Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors. Eur J Pharmacol, 1996. 317(2–3): p. 257–62.
Ding, J., et al., RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci, 2006. 9(6): p. 832–42.
Costa, R.M., et al., Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron, 2006. 52(2): p. 359–69.
Maggio, R., et al., Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. J Neurochem, 1998. 71(6): p. 2439–46.
Kase, H., et al., Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease. Neurology, 2003. 61(11 Suppl 6): p. S97–100.
Rozas, G., et al., Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice. Neurosci Lett, 1998. 245(3): p. 151–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bamford, N.S., Cepeda, C. (2009). The Corticostriatal Pathway in Parkinson’s Disease. In: Tseng, KY. (eds) Cortico-Subcortical Dynamics in Parkinson's Disease. Contemporary Neuroscience. Humana Press. https://doi.org/10.1007/978-1-60327-252-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-60327-252-0_6
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-251-3
Online ISBN: 978-1-60327-252-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)